Related Experiment Video
Updated: Jun 10, 2025
07:02
Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
Published on: September 9, 2020
6.2K
Transcatheter Myotomy for Hypertrophic Obstructive Cardiomyopathy
Barbara Danek1, David Elison1, Christine J Chung1
1University of Washington Medical Center, 1959 NE Pacific St, Seattle, WA, 98195, USA.
Current Cardiology Reports
|October 19, 2024
Summary
Transcatheter septal myotomy offers a new treatment for hypertrophic obstructive cardiomyopathy, improving symptoms and reducing obstruction. This minimally invasive procedure shows promise for patients unsuitable for surgery, with low complication rates.
Area of Science:
- Interventional Cardiology
- Cardiovascular Medicine
- Structural Heart Disease
Background:
- Hypertrophic obstructive cardiomyopathy (HOCM) is characterized by left ventricular outflow tract (LVOT) obstruction.
- Traditional treatments for HOCM often involve invasive surgery.
- Transcatheter ventricular septal defect closure (TMVR) is a procedure that can carry a risk of LVOT obstruction.
Purpose of the Study:
- To review the emerging role of transcatheter septal myotomy (TSM).
- To evaluate TSM as a treatment for LVOT obstruction in hypertrophic obstructive cardiomyopathy.
Main Methods:
- Review of existing literature and clinical data on transcatheter septal myotomy.
- Analysis of patient outcomes, including symptom improvement, gradient reduction, and procedural safety.
Main Results:
- Transcatheter septal myotomy has been successfully applied in patients with HOCM-related LVOT obstruction.
- The procedure demonstrates significant improvement in patient symptoms and reduction in LVOT gradients.
- Transcatheter septal myotomy is associated with a low incidence of procedural complications and a low risk of conduction abnormalities.
Conclusions:
- Transcatheter septal myotomy presents a novel, minimally invasive option for managing LVOT obstruction in HOCM.
- It is particularly beneficial for patients who are not ideal candidates for surgical myectomy.
- Further research is required to establish optimal patient selection criteria and assess long-term outcomes.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
1
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
1
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
2
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
2
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
1
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
1
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:14Myocarditis III: Medical Management
2
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2